Free shipping on all orders over $ 500

BMS-193885

Cat. No. M7642
BMS-193885 Structure
Size Price Availability Quantity
5mg USD 150  USD150 In stock
10mg USD 240  USD240 In stock
25mg USD 480  USD480 In stock
50mg USD 760  USD760 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BMS-193885 is a potent, selective Y1 antagonist that is active in both acute and chronic animal models of food intake. Although it is active in vivo, it is not orally bioavailable due to poor intestinal absorption, so it is not being pursued for pharmaceutical development. BMS-193885 has been used as a pre-clinical proof of concept tool for showing efficacy of Y1 antagonism in treating obesity.

Chemical Information
Molecular Weight 590.71
Formula C33H42N4O6
CAS Number 186185-03-5
Solubility (25°C) DMSO: ≥10 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Kazunori Kawamura, et al. Radiosynthesis and in vivo evaluation of 11 C-labeled BMS-193885 and its desmethyl analog as PET tracers for neuropeptide Y1 receptors

[2] Zhenlin Yang, et al. Structural basis of ligand binding modes at the neuropeptide Y Y 1 receptor

[3] Katarzyna Kaczyńska, et al. Activation of neuropeptide Y(2) receptors exerts an excitatory action on cardio-respiratory variables in anaesthetized rats

[4] Ildiko Antal-Zimanyi, et al. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist

[5] Graham S Poindexter, et al. Dihydropyridine neuropeptide Y Y1 receptor antagonists 2. bioisosteric urea replacements

Related Neuropeptide Receptor Products
Neuropeptide Y (human, rat, mouse) TFA

Neuropeptide Y (human, rat, mouse) TFA is involved in Alzheimer's disease (AD) and protects rat cortical neurons against β-Amyloid toxicity.

N-Acetyl [Leu28, Leu31] neuropeptide Y (24–36)

N-Acetyl [Leu28, Leu31] neuropeptide Y (24–36) is a selective agonist of neuropeptide Y Y2 receptor.

Neuropeptide Y (13-36), amide, human

Neuropeptide Y (13-36), amide, human is a selective neuropeptide Y2 receptor agonist.

Neuropeptide FF

Neuropeptide FF (NPFF), an octapeptide belonging to the RF-amide family of peptides, interacts with two distinct G-protein-coupled receptors, NPFF(1) and NPFF(2).

CART(55-102) (human)

CART(55-102)(human) is an endogenous satiety factor with potent appetite-suppressing activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: BMS-193885 supplier, Neuropeptide Receptor, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.